Načítá se...
Late Aminophylline Reversal of Regadenoson Stress Testing in Patients with End Stage Renal Disease
Regadenoson is a widely used and well-tolerated vasodilator agent for pharmacologic stress myocardial perfusing imaging. In patients at higher risk of adverse reactions such as those with end stage renal disease, it can be reversed with early administration of aminophylline. However, little is known...
Uloženo v:
| Hlavní autoři: | , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Medknow Publications & Media Pvt Ltd
2014
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4150159/ https://ncbi.nlm.nih.gov/pubmed/25191132 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/1450-1147.139148 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|